Drug
Choironex Galko Porcine Thymokidney
Choironex Galko Porcine Thymokidney: highest development phase Phase 1, developed by Xeno Holdings (US), LLC dba ChoironeX. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Xeno Holdings (US), LLC dba ChoironeX
Trials
| Drug | Phase | Indication |
|---|---|---|
| ChoironeX GalKO Porcine Thymokidney NCT07696962 | Phase 1 | End Stage Renal Disease |
Latest
No recent events.
Follow Choironex Galko Porcine Thymokidney on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.